–
Sarepta Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
billions USD
FY21:
FY22:
0.79
FY23:
1.09
FY24:
1.58
FY25:
2.17
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.46
FY22:
−0.54
FY23:
−0.27
FY24:
0.22
FY25:
−0.70
(positive)
Change from FY22 to FY24
billions USD
FY21:
–
FY22:
−0.47
FY23:
−0.03
FY24:
0.32
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.42
FY22:
−0.69
FY23:
−0.52
FY24:
0.26
FY25:
−0.70
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.42
FY22:
−0.70
FY23:
−0.54
FY24:
0.24
FY25:
−0.71
All amounts in billions USD